Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep1150 | Thyroid cancer | ECE2016

Can we predict malignancy in AUS/FLUS by measuring TSH?

Marques Ricardo Rodrigues , Rafael Ana Alves , Santos Francisco Sousa , Silva Silvia Sofia , Duarte Joao Sequeira , Fernandes Luis Viana

Background: Fine-needle aspiration (FNA) is an important test for triaging patients with thyroid nodules and differentiating benign from malignant disease. According to Bethesda System Classification, the rate of AUS/FLUS is between 3–6% of all FNA. The malignancy risk is of 5–15%. TSH levels might be associated to the likelihood of malignancy in thyroid nodules according to some studies. Our aim was to establish a possible correlation between TSH level and malignanc...